These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 12520875)

  • 1. Preventing sexual transmission of HSV and HIV: the challenge for active and passive immunization of mucosal surfaces.
    Zeitlin L; Palmer C; Whaley KJ
    Biotechnol Genet Eng Rev; 2002; 19():121-38. PubMed ID: 12520875
    [No Abstract]   [Full Text] [Related]  

  • 2. How do viral and host factors modulate the sexual transmission of HIV? Can transmission be blocked?
    Gupta K; Klasse PJ
    PLoS Med; 2006 Feb; 3(2):e79. PubMed ID: 16492075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Female genital tract immunity: distinct immunological challenges for vaccine development.
    Naz RK
    J Reprod Immunol; 2012 Jan; 93(1):1-8. PubMed ID: 22154945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of innate immune responses in the female genital tract: friend or foe of HIV-1 infection?
    Firoz Mian M; Ashkar AA
    Am J Reprod Immunol; 2011 Mar; 65(3):344-51. PubMed ID: 21223417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and HIV Transmission in Sub-Saharan Africa.
    Kaul R; Prodger J; Joag V; Shannon B; Yegorov S; Galiwango R; McKinnon L
    Curr HIV/AIDS Rep; 2015 Jun; 12(2):216-22. PubMed ID: 25877253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges for vaccination against sexually-transmitted diseases: induction and long-term maintenance of mucosal immune responses in the female genital tract.
    Rosenthal KL; Gallichan WS
    Semin Immunol; 1997 Oct; 9(5):303-14. PubMed ID: 9327525
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of microbicides and sexually transmitted infections on mucosal immunity in the female genital tract.
    Keller MJ; Herold BC
    Am J Reprod Immunol; 2006; 56(5-6):356-63. PubMed ID: 17076680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal immunity in the male and female reproductive tract and prevention of HIV transmission.
    Wira CR; Veronese F
    Am J Reprod Immunol; 2011 Mar; 65(3):182-5. PubMed ID: 21294802
    [No Abstract]   [Full Text] [Related]  

  • 9. Prospects for passive immunity to prevent HIV infection.
    Morris L; Mkhize NN
    PLoS Med; 2017 Nov; 14(11):e1002436. PubMed ID: 29136030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Unprotected fellatio: what are the risks?].
    Genné D
    Rev Med Suisse; 2013 Oct; 9(401):1828-31. PubMed ID: 24191417
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An African perspective on mucosal immunity and HIV-1.
    Pala P; Gomez-Roman VR; Gilmour J; Kaleebu P
    Mucosal Immunol; 2009 Jul; 2(4):300-14. PubMed ID: 19421180
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B cell and T cell immunity in the female genital tract: potential of distinct mucosal routes of vaccination and role of tissue-associated dendritic cells and natural killer cells.
    Anjuère F; Bekri S; Bihl F; Braud VM; Cuburu N; Czerkinsky C; Hervouet C; Luci C
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():117-22. PubMed ID: 22882377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A summary of the workshop on passive immunization using monoclonal antibodies for HIV/AIDS, held at the National Institute of Allergy and Infectious Diseases, Bethesda, 10 March 2006.
    Bansal GP
    Biologicals; 2007 Oct; 35(4):367-71. PubMed ID: 17889555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The genital tract immune milieu: an important determinant of HIV susceptibility and secondary transmission.
    Kaul R; Pettengell C; Sheth PM; Sunderji S; Biringer A; MacDonald K; Walmsley S; Rebbapragada A
    J Reprod Immunol; 2008 Jan; 77(1):32-40. PubMed ID: 17395270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody to HSV gD peptide induced by vaccination does not protect against HSV-2 infection in HSV-2 seronegative women.
    Gilbert PB; Excler JL; Tomaras GD; Carpp LN; Haynes BF; Liao HX; Montefiori DC; Rerks-Ngarm S; Pitisuttithum P; Nitayaphan S; Kaewkungwal J; Kijak GH; Tovanabutra S; Francis DP; Lee C; Sinangil F; Berman PW; Premsri N; Kunasol P; O'Connell RJ; Michael NL; Robb ML; Morrow R; Corey L; Kim JH
    PLoS One; 2017; 12(5):e0176428. PubMed ID: 28493891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Specific mucosal immunity in the female reproductive tract: protection against infectious diseases and regulation of fertility (part 2)].
    Zivný J; Sterzl I
    Ceska Gynekol; 2003 Jul; 68(4):254-8. PubMed ID: 14515648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines and microbicides preventing HIV-1, HSV-2, and HPV mucosal transmission.
    Nikolic DS; Piguet V
    J Invest Dermatol; 2010 Feb; 130(2):352-61. PubMed ID: 19829304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral immune responses to the human immunodeficiency virus type-1 (HIV-1) in the genital tract compared to other mucosal sites.
    Mestecky J
    J Reprod Immunol; 2006 Dec; 72(1-2):1-17. PubMed ID: 17095369
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral manifestations of sexually transmitted infections.
    Mastrolorenzo A; Giomi B; Tiradritti L; Zuccati G
    G Ital Dermatol Venereol; 2012 Aug; 147(4):373-88. PubMed ID: 23007212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV vaccine and genital secretory immune response.
    Stefanache-Guihard AI
    Rom J Virol; 1995; 46(1-2):85-98. PubMed ID: 9106405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.